Incorporation of cholesterol oxidation products into cell lipids and their influence on the proliferation of cultured cardiomyocytes

• Published in: Cardioscience Vol. 6; no. 2; p. 107
• Main Authors: Bordoni, A, Hrelia, S, Caboni, M F, Lercker, G, Biagi, P L
• Format: Journal Article
• Language: English
• Published: Italy 01.06.1995
• Subjects: Animals; Cell Division - drug effects; Cell Division - physiology; Cell Membrane Permeability - drug effects; Cells, Cultured; Cholesterol - metabolism; Cholesterol - pharmacology; Heart - drug effects; Intracellular Fluid - drug effects; Intracellular Fluid - metabolism; Lipid Metabolism; Myocardium - cytology; Oxidation-Reduction; Proteins - drug effects; Proteins - metabolism; Rats; Rats, Wistar
• ISSN: 1015-5007

We have investigated the incorporation of cholesterol oxidation products into cardiomyocyte lipids and related this to changes in cell proliferation, evaluated by measuring cellular protein content. Primary cultures of neonatal rat ventricular cells were supplemented with scalar concentrations of several cholesterol oxidation products (cholestan-5 alpha, 6 alpha-epoxy-3 beta-ol, 5 alpha-cholestane-3 beta, 5, 6 beta-triol, 5-cholesten-3 beta, 4 beta-diol, 5-cholesten-3 beta-ol-7-one, and 5-cholesten-3-one). Although all the cholesterol oxidation products were incorporated into the cardiomyocyte lipids when added to the medium at a concentration higher than 0.5 microM, the extent of the incorporation of the different cholesterol oxidation products differed, depending on the concentration in the culture medium and on the chemical structure of the compound. The effects of the cholesterol oxidation products on the cellular protein content were also different: 5 alpha-cholestane-3 beta, 5, 6 beta-triol was shown to be the most potent inhibitor of cell proliferation, followed by cholestan-5 alpha, 6 alpha-epoxy-3 beta-ol, 5-cholesten-3 beta, 4 beta-diol and 5-cholesten-3 beta-ol-7-one. 5-Cholesten-3-one did not affect the cellular protein content. The ability of cholesterol oxidation products to inhibit cell proliferation, and their capacity to increase the permeability of the plasma membrane to calcium, could be deleterious for cardiac cells.